CBRE reports second-quarter results on July 23 with the stock trading at $140.96 — roughly 20% below where analysts collectively think it belongs.
The most striking feature of the setup is the gap between current price and analyst conviction. The consensus price target sits at $176, implying upside of around 25%. That gap has widened materially since early in the year, when target prices clustered near $190 and the stock was trading close to its 52-week high. Evercore ISI trimmed its target to $169 at end-June while holding its Outperform rating — a sign that even the bulls are recalibrating on valuation rather than abandoning the thesis. The broader direction from covered analysts is constructive but increasingly selective, with targets stepped down from late-2024 peaks across multiple firms.
The bull case rests on structural outsourcing tailwinds and the gradual shift toward more contractual, recurring fee revenue — both of which reduce CBRE's sensitivity to transaction volume cycles. Bears counter that the stock still trades at 17-18x trailing earnings and roughly 12.5x EV/EBITDA, which is the upper end of cyclical recovery valuations for a business with meaningful exposure to capital markets activity. That tension is the core of the Q2 debate: whether advisory and transaction segments show enough momentum to justify holding the multiple, or whether slowing deal flow compresses near-term numbers and pushes the re-rating further out.
The lending market and short positioning offer no real signal either way. Short interest is a modest 1.9% of the free float — low by any measure — and has edged down roughly 6% on the week. Borrow availability is extremely loose at over 8,000% of short interest, and cost to borrow sits near 0.52%, barely above zero. Options positioning is also calm: the put/call ratio of 0.55 runs only modestly above its 20-day average, well inside one standard deviation. CBRE's closest peers — JLL, CWK, and NMRK — all fell roughly 1.5–2.8% on Thursday, broadly in line with CBRE's own 1.9% slip, suggesting the sector is moving together rather than any stock-specific anxiety ahead of the print.
One note of caution in the ownership picture: insiders sold net shares worth roughly $10 million in the 90 days to mid-May, including a $3.6 million sale by CEO Robert Sulentic in March. Those transactions occurred near current price levels, which the market may weigh against the bullish analyst tone. The print will test whether CBRE's advisory revenue is inflecting in ways that close the gap between the stock's actual trading level and where analysts believe fair value sits.
See the live data behind this article on ORTEX.
Open CBRE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
